Skip to Content
Credit Insights

Takeovers: Rumors and Candidates

Investors should pay attention to bond covenants as buyout activity heats up.

Mentioned: , , , , , , , , ,

Early last week, rumors surfaced that  Sara Lee (ticker: (SLE), rating: BBB) had been approached by KKR with a takeover offer that was rebuffed. This rumor led to a hunt across the rest of the consumer product sector to identify other leveraged buyout targets. Pretty much anything with a market capitalization below $10 billion is now considered as potentially being in play. Names like  Clorox (ticker: (CLX), rating: A-),  ConAgra (ticker: (CAG), rating: A-),  Fortune Brands (ticker: (FO), not rated), and  Newell Rubbermaid (ticker: (NWL), rating: BBB-) all experienced significant bids in their credit default swaps. As the week wore on, the market expanded its search for LBO candidates to the retail sector, where  Limited Brands (ticker: (LTD), rating: BB+) was discussed as a candidate. With private equity firms sitting on more than $400 billion in uncommitted capital available for takeovers, we expect an uptick in LBO deals in the near term, particularly while interest rates are low and before capital commitments must be released to investors.

We are not surprised that Sara Lee may have become an LBO target, given its respectable free cash flow characteristics (it generates a free cash flow yield in the midsingle digits) and debt/EBITDA of less than 2 times. In addition, the firm has been in limbo since the departure of CEO Brenda Barnes for health reasons in August, and KKR may consider this a window of opportunity. On the basis of our preliminary LBO model analysis, which considers $4.6 billion-$5.1 billion in added leverage (4.0-4.5 times our projected fiscal 2010 EBITDA), an exit multiple of 8 times, and a required internal rate of return of 15%-18%, we view $13-$15 per share as a reasonable takeout range.

David Sekera does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.